Results 11 to 20 of about 690,446 (299)

Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps. [PDF]

, 2016
Information on exposure to, and health effects of, cardiovascular disease (CVD) risk factors is needed to develop effective strategies to prevent CVD events and deaths.
Elliott, P, Ezzati, M, Kontis, V, Tzoulaki, I   +3 more
core   +1 more source

Risk factors for death among children 0–59 months of age with moderate-to-severe diarrhea in Manhiça district, southern Mozambique

BMC Infectious Diseases, 2019
Background Despite major improvements in child survival rates, the number of deaths due to diarrhea remains unacceptably high. We aimed to describe diarrhea-associated mortality and evaluate risk factors for death among Mozambican children with moderate ...
Sozinho Acácio, Inácio Mandomando, Tacilta Nhampossa, Llorenç Quintó, Delfino Vubil, Charfudin Sacoor, Karen Kotloff, Tamer Farag, Dilruba Nasrin, Eusébio Macete, Myron M. Levine, Pedro Alonso, Quique Bassat   +12 more
doaj   +1 more source

Effect of substrate roughness on the nucleation and growth behaviour of microwave plasma enhanced CVD diamond films – a case study

Functional Diamond, 2023
The influence of substrate surface roughness on the nucleation and growth of diamond films by chemical vapour deposition (CVD) is investigated. Silicon substrates were grinded with six different grit sizes of abrasive papers with a rotating wheel. Si was
Awadesh Kumar Mallik, Rozita Rouzbahani, Fernando Lloret, Rani Mary Joy, Ken Haenen   +4 more
doaj   +1 more source

Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations [PDF]

, 2015
Background: All rigorous primary cardiovascular disease (CVD) prevention guidelines recommend absolute CVD risk scores to identify high- and low-risk patients, but laboratory testing can be impractical in low- and middle-income countries.
Gaziano, Thomas A, Joubert, Gina, Kruger, Annamarie, Laubscher, Ria, Levitt, Naomi, Mollentze, Willie, Motala, Ayesha A, Naidoo, Datshana P, Pandya, Ankur, Prakaschandra, Dorcas R, Schutte, Aletta E, Steyn, Krisela, Walsh, Corinna M   +12 more
core   +1 more source

Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease [PDF]

, 2015
Cardiovascular disease (CVD) still represents the leading cause of mortality and morbidity worldwide. Despite considerable improvements in the prognosis of CVD and the significant reduction of CVD mortality obtained during the past half century, patients
Battistoni, Allegra, Mastromarino, Vittoria, Volpe, Massimo   +2 more
core   +1 more source

Role of oxidative stress, gut microbiota and derived metabolites in the etiology and progression of nonalcoholic fatty liver disease

Redox Experimental Medicine, 2023
Nonalcoholic fatty liver disease or NAFLD is a complex and multifactorial liver disease that is affecting a majority of the world’s population now more than ever.
Ankita Das, Arka Jyoti De, Tanuja Mohanty, Palok Aich   +3 more
doaj   +1 more source

The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent [PDF]

, 2018
Aims: The data regarding the associations of body mass index (BMI) with cardiovascular (CVD) risk, especially for those at the low categories of BMI, are conflicting. The aim of our study was to examine the associations of body composition (assessed by
Anderson, Jana, Celis-Morales, Carlos A., Gill, Jason M.R., Gray, Stuart R., Iliodromiti, Stamatina, Lyall, Donald M., Mackay, Daniel F., Nelson, Scott M., Pell, Jill P., Sattar, Naveed, Welsh, Paul   +10 more
core   +1 more source

Shared decision-making about cardiovascular disease medication in older people: A qualitative study of patient experiences in general practice [PDF]

, 2019
Objectives To explore older people's perspectives and experiences with shared decision-making (SDM) about medication for cardiovascular disease (CVD) prevention.
Bonner, Carissa, Doust, Jenny, Jansen, Jesse, McCaffery, Kirsten, McKinn, Shannon, Muscat, Danielle Marie   +5 more
core   +2 more sources

Assessing the Policy Landscape for Salt Reduction in South-East Asian and Latin American Countries – An Initiative Towards Developing an Easily Accessible, Integrated, Searchable Online Repository

Global Heart, 2021
Background: High dietary salt intake is an avoidable cause of hypertension and associated cardiovascular diseases (CVDs). Thus, salt reduction is recommended as one of the most cost-effective interventions for CVD prevention and for achieving the World ...
Aprajita Kaushik, Frank Peralta-Alvarez, Priti Gupta, Juan Carlos Bazo-Alvarez, Sandra Ofori, Kirsty Bobrow, Dan Monyeki, Renzo R. Guinto, Jill Baumgartner, Sailesh Mohan   +9 more
doaj   +1 more source

Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk [PDF]

, 2011
<p><b>Objective:</b> The goal of this study was to examine the association of the antiinflammatory interleukin-10 (IL-10) with risk of cardiovascular disease (CVD).</p> <p><b>Methods and Results:</b> In the ...
Craen, A.J.M. de, Ford, I., Jukema, J.W., McInnes, I.B., Murray, H.M., Packard, C.J., PROSPER Study Grp, Sattar, N., Stott, D.J., Trompet, S., Welsh, P., Westendorp, R.G.J.   +11 more
core   +1 more source